Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 4 15Phase 3 15Phase NA 4Phase 1 3Phase 2/3 2Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 5CNS 5Plasma cell 3Genitourinary 3Breast 3Gynecologic 2Tumor-Agnostic 1Thoracic 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Lung Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Zoledronic Acid × Genitourinary × Clear all
NCT00004928 2013-06-19

Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

NCT00264420 2010-12-21

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

The Cleveland Clinic

Phase 1 Completed
4 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT00415779 2010-02-24

ZANTE

National Cancer Institute, Naples

Phase 1 Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡